• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Endocrinology

Deep-learning model achieved high diagnostic performance for diabetic macular edema detection using optical coherence tomography (OCT) scans

byCheng En Xi
September 10, 2026
in Endocrinology, Ophthalmology
Reading Time: 2 mins read
A glucose meter, a droplet of liquid, and abstract representations of data and research materials, symbolizing diabetes management and detection methods.
Share on FacebookShare on TwitterShare on LinkedIn

1. Nguyen and colleagues developed and evaluated a deep-learning model for detecting diabetic macular edema using 3D OCT scans.

2. The model achieved accuracy, sensitivity, and specificity above 90% in a real-world screening program and flagged uncertain cases for specialist review.

Evidence Rating Level: 2 (Good)

Study Rundown: Diabetic macular edema (DME) is the primary cause of vision loss among individuals with diabetes, and early detection of DME is crucial for preventing and delaying visual impairment. Nguyen and colleagues developed a privacy-preserving deep-learning model to detect DME and distinguish center-involved DME (CI-DME) from non-CI-DME using 3D OCT scans. The model was trained through federated learning on multicenter data without transferring patient images between institutions. The model was then prospectively evaluated in a diabetic retinopathy screening program in Vietnam. The main performance metrics were accuracy, sensitivity, specificity, and comparisons with ophthalmologists. The study found that the model achieved an accuracy of 93.70%, a sensitivity of 91.78%, and a specificity of 93.06%. Diagnostic performance was lower for distinguishing CI-DME from non-CI-DME. The model also identified 64 uncertain cases for ophthalmologist review and performed similarly to human experts. This study demonstrated that a deep-learning model can be used to expand DME screening in lower-resourced settings.

Click here to read the study in NEJM AI

Relevant Reading: Real-world performance of an AI system for diabetic retinopathy screening

RELATED REPORTS

An artificial intelligence system for human papillomavirus-positive dual stain cervical cancer screening reads p16-Ki67 slides

An artificial intelligence model demonstrates the potential for improving the efficiency of structural heart disease screening using electrocardiograms

In-Depth [prospective cohort]: The model was developed and evaluated using 8,031 OCT volumes from 1,958 adults across five centers in Hong Kong, Singapore, and the United States. Three Hong Kong datasets were used for federated training, while Singaporean and American datasets were used for external retrospective testing. The model first detected DME and then classified positive scans as CI-DME or non-CI-DME. Federated averaging enabled collaborative training without sharing patient images. For prospective testing, 1,473 OCT volumes from 753 consecutively recruited participants in a Vietnamese diabetic retinopathy screening program were analyzed in real time. OCT scans were classified as positive, negative, or uncertain; uncertain cases were referred to ophthalmologists. Performance metrics included area under the receiver operating characteristic curve (AUROC), accuracy, sensitivity, and specificity. The model achieved 93.70% accuracy (95% confidence interval [CI], 91.24-94.01%), 91.78% sensitivity (95% CI, 86.84-94.36%), and 93.06% specificity (95% CI, 91.53-94.49%) for DME detection. CI-DME classification achieved 83.75% accuracy (95% CI, 78.17-88.83%), 85.61% sensitivity (95% CI, 79.56-91.17%), and 79.31% specificity (95% CI, 68.75-89.09%). A total of 64 cases were identified as uncertain and were referred to ophthalmologists. This study was limited by the use of a single commercial OCT device, imperfect specificity that could increase referrals, and uncertainty regarding the optimal management of borderline cases. Overall, this study demonstrated that DME can be effectively screened using a deep-learning model to expand access in lower-resourced settings.

Image: PD

©2026 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: artificial intelligencedeep learningdiabetesdiabetic macular edema
Previous Post

FDA-cleared AI devices rarely have patient outcome data

Next Post

Chronic exposure to particulate matter is associated with increased cardiovascular risk

RelatedReports

A calendar, a specimen jar, and a brush are depicted alongside a microscopic view of cervical cells, indicating cervical cancer screening.
All Specialties

An artificial intelligence system for human papillomavirus-positive dual stain cervical cancer screening reads p16-Ki67 slides

October 23, 2026
An illustration featuring a heart within a house, with a stethoscope, a scale, and medication, symbolizing heart failure home hospital care.
Artificial Intelligence

An artificial intelligence model demonstrates the potential for improving the efficiency of structural heart disease screening using electrocardiograms

October 21, 2026
A sleeping child with electrodes on the scalp, surrounded by a moon and night sky, illustrating sleep monitoring and brain health assessment.
Artificial Intelligence

Deep learning model demonstrates potential to generate an interpretable brain health biomarker from sleep electroencephalography

October 19, 2026
A woman engages with a mental health app on her phone, while another woman provides support. The image symbolizes the connection between technology and mental well-being.
Artificial Intelligence

Artificial intelligence (AI)-powered mental health app demonstrated improved social well-being among users

October 15, 2026
Next Post
A senior woman looks thoughtfully at a balance scale with a stethoscope and a heart illustration, symbolizing the assessment of cardiovascular risk and treatment decisions.

Chronic exposure to particulate matter is associated with increased cardiovascular risk

An artistic illustration featuring an elderly woman with a brain overlay, an open book suggesting knowledge or guidance, and various medical symbols related to neurology and surgery.

Real-time AI guidance enters live brain tumor surgery

A man sits pensively by a window with a depiction of a synapse illustrating neurotransmitter activity, suggesting a focus on mental health treatment mechanisms.

Artificial intelligence (AI) chatbot reduced depression, anxiety, and eating disorder risk symptoms

✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • An electronic health record tool for exercise prescription may reduce fall rate among older adults
  • Optogenetic therapy may partially restore vision in retinitis pigmentosa
  • An artificial intelligence system for human papillomavirus-positive dual stain cervical cancer screening reads p16-Ki67 slides
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.